Literature DB >> 28920449

The relationship between migraine and rosacea: Systematic review and meta-analysis.

Casper Emil Christensen1, Frederikke Schelde Andersen1, Nita Wienholtz1, Alexander Egeberg2, Jacob P Thyssen2, Messoud Ashina1.   

Abstract

Objective To systematically review the association between migraine and rosacea. Background Migraine is a complex disorder with episodes of headache, nausea, photo- and phonophobia. Rosacea is an inflammatory skin condition with flushing, erythema, telangiectasia, papules, and pustules. Both are chronic disorders with exacerbations of symptoms almost exclusively in areas innervated by the trigeminal nerve. Previous studies found an association between these disorders. We review these findings, provide a meta-analysis, and discuss possible pathophysiological commonalities. Methods A search through PubMed and EMBASE was undertaken for studies investigating the association between all forms of migraine and rosacea published until November 2016, and meta-analysis of eligible studies. Results Nine studies on eight populations were identified. Studies differed in methodology and diagnostic process, but all investigated co-occurrence of migraine and rosacea. Four studies were eligible for meta-analysis, resulting in a pooled odds ratio of 1.96 (95% confidence interval 1.41-2.72) for migraine in a rosacea population compared to a non-rosacea population. Conclusion Our meta-analysis confirmed an association in occurrence of migraine and rosacea. Future studies should specifically investigate possible shared pathophysiological mechanisms between the two disorders.

Entities:  

Keywords:  Pathophysiology; neuroinflammation; neurovascular; phenotype

Mesh:

Year:  2017        PMID: 28920449     DOI: 10.1177/0333102417731777

Source DB:  PubMed          Journal:  Cephalalgia        ISSN: 0333-1024            Impact factor:   6.292


  7 in total

1.  Serum Level of Brain-Derived Neurotrophic Factor (BDNF) Associated with Depression in Patients with Rosacea: A Candidate Predictive Biomarker.

Authors:  Tegexibaiyin Wang; Fen Liu; Xiujuan Jia; Jing Tan; Baopeng Qi; Jingxue Guo; Qiri Mu; Hong Zhang
Journal:  Clin Cosmet Investig Dermatol       Date:  2022-06-02

2.  Risk of Migraine in Europeans with Low Melanin Levels-A Population Based Case-Control Study.

Authors:  Magdalena Kobus; Elżbieta Żądzińska; Aneta Sitek; Jacek Pełka; Jacek J Rożniecki; Bogusław Antoszewski
Journal:  Brain Sci       Date:  2022-05-10

3.  Burden of migraine in Finland: multimorbidity and phenotypic disease networks in occupational healthcare.

Authors:  Minna A Korolainen; Samuli Tuominen; Samu Kurki; Mariann I Lassenius; Iiro Toppila; Timo Purmonen; Jaana Santaholma; Markku Nissilä
Journal:  J Headache Pain       Date:  2020-01-31       Impact factor: 7.277

Review 4.  Updates on the Risk of Neuropsychiatric and Gastrointestinal Comorbidities in Rosacea and Its Possible Relationship with the Gut-Brain-Skin Axis.

Authors:  Yu Ri Woo; Yu Jin Han; Hei Sung Kim; Sang Hyun Cho; Jeong Deuk Lee
Journal:  Int J Mol Sci       Date:  2020-11-10       Impact factor: 5.923

5.  Subtype-Specific Off-Label Treatment of Rosacea.

Authors:  Nita Wienholtz; Messoud Ashina; Jacob P Thyssen; Alexander Egeberg
Journal:  Case Rep Dermatol       Date:  2021-02-16

6.  Evaluation of fibromyalgia syndrome in patients with rosacea.

Authors:  Emine Müge Acar; Hilal Kaya Erdoğan; Senem Şaş; Ersoy Acer
Journal:  Arch Rheumatol       Date:  2021-01-14       Impact factor: 1.472

7.  Cohort profile: COpenhagen ROsacea COhort (COROCO) and COpenhagen MIgraine COhort (COMICO).

Authors:  Nita Katarina Frifelt Wienholtz; Casper Emil Christensen; Jeanette Halskou Haugaard; Ditte Georgina Zhang; Messoud Ashina; Jacob Pontoppidan Thyssen; Alexander Egeberg
Journal:  BMJ Open       Date:  2020-08-20       Impact factor: 2.692

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.